Immunodeficiency Syndromes

• EMA approval · 2025-05-28
  EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH

  Privigen (human normal immunoglobulin IVIg) has been authorised by the EMA for multiple indications. The listed therapeutic areas include id…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes [Phase 2]

  A completed Phase 2 pilot trial evaluating the combination of all-trans retinoic acid and interferon-alpha2a for lymphoproliferative disorde…